Immediate Imaging with CT Scan is Essential—This is Likely Urolithiasis or Chemotherapy-Related Urothelial Toxicity
In a 73-year-old woman on chemotherapy presenting with right flank pain, abdominal cramping, and urinary urgency/frequency despite a normal UA 2 days ago, you must obtain urgent imaging with ultrasound followed by non-contrast CT scan to rule out urolithiasis and assess for hydronephrosis or chemotherapy-induced inflammatory ureteritis/cystitis. 1, 2
Diagnostic Approach
Why the Normal UA Doesn't Rule Out Serious Pathology
- Urolithiasis remains highly likely despite the recent normal urinalysis. Urine dipstick has limited sensitivity (45% for ultrasound detection of stones), and a stone can cause obstruction and pain without immediate pyuria or hematuria 1
- Chemotherapy-associated urothelial toxicity can present with these exact symptoms and may not show abnormalities on routine urinalysis initially 2
- In elderly patients, urinary symptoms are often atypical and non-specific 3
Immediate Diagnostic Steps
Start with bedside ultrasound to assess for:
Proceed directly to non-contrast CT scan (the gold standard):
Obtain fresh urinalysis with microscopy (not just dipstick):
- Negative dipstick for nitrite AND leukocyte esterase has reasonable negative predictive value 3
- However, microscopy may reveal findings missed on dipstick
- Send urine culture if any abnormality detected
Blood work: creatinine, CBC, CRP to assess for:
- Acute kidney injury from obstruction
- Systemic inflammation
- Infection markers 1
Critical Differential Diagnoses to Consider
Most Likely: Urolithiasis
- Right-sided flank pain with urinary symptoms is classic
- Stone passage can occur with intermittently normal UA
- Requires urgent imaging to assess for obstruction 1
Chemotherapy-Induced Urothelial Toxicity
- This is an underrecognized but serious complication 2
- Can present with hematuria, flank pain, urinary urgency/frequency
- May show hydronephrosis and inflammatory fat stranding on CT
- A recent case report documented severe inflammatory cystitis and ureteritis after docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) therapy requiring corticosteroids 2
- If CT shows hydroureter with inflammatory changes but no stone, consider this diagnosis
Less Likely but Important
- Complicated UTI (pyelonephritis) - though less likely with normal recent UA
- Tumor-related obstruction (given cancer history)
- Radiation cystitis if she has had pelvic radiation 4, 5
Management Algorithm
If Stone Disease Confirmed:
Pain control: NSAIDs (diclofenac, ibuprofen) are first-line over opioids 1
- Use lowest effective dose given cardiovascular/GI risks in elderly
Stone size determines management:
- <5mm: Conservative management with hydration, analgesia
- 5-10mm: Consider medical expulsive therapy
10mm or signs of obstruction: Urology consultation for intervention 1
Monitor for complications: fever, worsening renal function, intractable pain requiring urgent intervention
If Inflammatory Ureteritis/Cystitis Suspected:
- Rule out infection with culture
- Consider corticosteroids (prednisolone 60mg daily) if imaging shows inflammatory changes without stone and symptoms persist despite supportive care 2
- Oncology consultation regarding chemotherapy continuation
- Supportive care: hydration, bladder irrigation if hematuria develops
If Imaging is Negative:
- Reassess for non-urological causes of abdominal pain
- Consider gynecological pathology
- Evaluate for constipation (common in elderly on chemotherapy)
Critical Pitfalls to Avoid
- Don't assume the normal UA from 2 days ago excludes current pathology—clinical picture trumps old labs
- Don't anchor on UTI in elderly patients with atypical presentations; broader differential is essential 3
- Don't miss chemotherapy-related complications—this is increasingly recognized with modern regimens 2
- Don't delay imaging waiting for symptoms to evolve—obstruction can cause permanent renal damage
- Don't use empiric antibiotics without clear evidence of infection (no fever, no systemic signs, normal recent UA) 3
The key is urgent imaging to differentiate between obstructive uropathy (stone), inflammatory toxicity (chemotherapy), and other causes—management diverges significantly based on this distinction.